{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:49:26Z","timestamp":1761598166550,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejphar.2020.172979","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T11:32:19Z","timestamp":1580470339000},"page":"172979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Vasoactive intestinal peptide infusion reverses existing renal interstitial fibrosis via a blood pressure independent mechanism in the rat"],"prefix":"10.1016","volume":"873","author":[{"given":"Karen A.","family":"Duggan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Trajanovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tegan","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Australian Institute of Health and Welfare","key":"10.1016\/j.ejphar.2020.172979_bib1"},{"key":"10.1016\/j.ejphar.2020.172979_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.semnephrol.2012.07.008","article-title":"Can we target tubular damage to prevent renal function decline in diabetes?","volume":"32","author":"Bonventre","year":"2012","journal-title":"Semin Nephrol. Semin Nephrol."},{"key":"10.1016\/j.ejphar.2020.172979_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12896-016-0256-y","article-title":"A simple, accurate and universal method for quantification of PCR","volume":"16","author":"Boulter","year":"2016","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ejphar.2020.172979_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrd.2016.67","article-title":"The next generation of therapeutics for chronic kidney disease","volume":"15","author":"Breyer","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejphar.2020.172979_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2020.172979_bib6","first-page":"172629","article-title":"Vasoactive intestinal peptide infusion reverses existing myocardial fibrosis in the rat Europ","volume":"862","author":"Duggan","year":"2019","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172979_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1681\/ASN.2010050546","article-title":"Where is the epidemic in kidney disease?","volume":"21","author":"Hsu","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2020.172979_bib8","first-page":"55","article-title":"Tubulointerstitial fibrosis: an emerging major health problem","volume":"27","author":"Klein","year":"2011","journal-title":"Med. Sci."},{"key":"10.1016\/j.ejphar.2020.172979_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000339649","article-title":"Mineralocorticoid receptor antagonism and aldosterone synthesis inhibition do not improve glomerulosclerosis and renal interstitial fibrosis in a model of chronic kidney allograft injury","volume":"35","author":"Lahmer","year":"2012","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ejphar.2020.172979_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00428-011-1100-3","article-title":"Afferent arteriolopathy and glomerular collapse but not segmental sclerosis induce tubular atrophy in old spontaneously hypertensive rats","volume":"459","author":"Leh","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ejphar.2020.172979_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2796.2010.02289.x","article-title":"The epidemic of chronic kidney disease: looking at ageing and cardiovascular disease through kidney-shaped lenses","volume":"268","author":"Mangione","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2020.172979_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2014-eular.4801","article-title":"AB0410\u2005Effect of anti-tumor necrosis factor Alpha treatment of rheumatoid arthritis and chronic kidney disease","volume":"73","author":"Moon","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2020.172979_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage.","volume":"20","author":"Nath","year":"1992","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.ejphar.2020.172979_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11255-009-9691-1","article-title":"Incidence of end-stage renal disease in the elderly: a steadily rising global socioeconomic epidemic","volume":"42","author":"Paraskevas","year":"2010","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ejphar.2020.172979_bib14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.169.3951.1217","article-title":"Polypeptide with broad biological activity: isolation from small intestine","volume":"169","author":"Said","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.172979_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00467-015-3169-4","article-title":"Tubular atrophy in the pathogenesis of chronic kidney disease progression","volume":"31","author":"Schelling","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2020.172979_bib16","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41598-017-01702-7","article-title":"A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-\u03b1 and TGF-\u03b21 pathways","volume":"7","author":"Shima","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.172979_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2009.03956.x","article-title":"Immunomodulation od innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease","volume":"157","author":"Smalley","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2020.172979_bib18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.lpm.2011.06.020","article-title":"Chronic renal failure: an epidemic?","volume":"40","author":"Stengel","year":"2011","journal-title":"Presse Med."},{"key":"10.1016\/j.ejphar.2020.172979_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2796.2010.02269.x","article-title":"Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease","volume":"268","author":"Stenvinkel","year":"2010","journal-title":"J. Intern. Med."},{"year":"2019","series-title":"Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","author":"United States Renal Data System USRDS","key":"10.1016\/j.ejphar.2020.172979_bib20"},{"key":"10.1016\/j.ejphar.2020.172979_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/hr.2009.106","article-title":"Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders","volume":"32","author":"Watanabe","year":"2009","journal-title":"Hypertens. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2020.172979_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin. Liver Dis."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920300716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920300716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:33:58Z","timestamp":1757975638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920300716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":23,"alternative-id":["S0014299920300716"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.172979","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasoactive intestinal peptide infusion reverses existing renal interstitial fibrosis via a blood pressure independent mechanism in the rat","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.172979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"172979"}}